935668-80-7Relevant articles and documents
DISUBSTITUTED PYRAZOLE COMPOUNDS
-
Paragraph 0097-0098, (2020/12/25)
The present invention provides a compound of Formula I or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and no
TAXANE COMPOUND WITH AZETIDINE RING STRUCTURE
-
Page/Page column 29, (2008/12/06)
A compound represented by the general formula (1) [X1 and X2 represent hydrogen atom, a halogen atom, hydroxyl group and the like, R1 represents a phenyl group, R2 represents an alkyl group, an alkenyl group, or